Clinical Trial Update: Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria [Phase 2]

View source ↗

Summary

A pilot Phase II study tested pramipexole in children and adolescents with Tourette syndrome; the trial completed and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Tourette Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-10-20